Drug-induced hyperprolactinemia: mechanism of development, features of diagnosis and treatment
- DOI
- 10.14341/omet13036
- Published
- 2023-11-14
- Container
- Obesity and metabolism
- Publisher
- Endocrinology Research Centre
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.14341/omet13036,
title = {Drug-induced hyperprolactinemia: mechanism of development, features of diagnosis and treatment},
author = {L. K. Dzeranova and S. Y. Vorotnikova and A. S. Shutova and E. A. Pigarova and M. I. Yevloyeva},
year = {2023},
journal = {Obesity and metabolism},
doi = {10.14341/omet13036},
url = {https://doi.org/10.14341/omet13036}
}RIS
TY - JOUR TI - Drug-induced hyperprolactinemia: mechanism of development, features of diagnosis and treatment AU - L. K. Dzeranova AU - S. Y. Vorotnikova AU - A. S. Shutova AU - E. A. Pigarova AU - M. I. Yevloyeva PY - 2023 JO - Obesity and metabolism DO - 10.14341/omet13036 UR - https://doi.org/10.14341/omet13036 ER -
APA
Dzeranova, L. K., Vorotnikova, S. Y., Shutova, A. S., Pigarova, E. A., & Yevloyeva, M. I. (2023). Drug-induced hyperprolactinemia: mechanism of development, features of diagnosis and treatment. Obesity and metabolism. https://doi.org/10.14341/omet13036
Source records
- crossref · retrieved 2026-09-25T22:20:08.213Z